A tau-induced transgenic mouse model of AD showed elevated levels of miR-92a, which targets the mitochondrial gene cytochrome b and disrupts γ-aminobutyric acid (GABA) transmission [65]. The gene discussed is MAPT; the disease is Alzheimer disease.